| Trial ID: | L2445 |
| Source ID: | NCT01548248
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Efficacy and Safety of Levemir® Used as Basal Insulin
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir|DRUG: insulin aspart
|
| Outcome Measures: |
Primary: Change in HbA1c (glycosylated haemoglobin) | Secondary: Change in weight|Change in fasting plasma glucose (FPG)|Change in 4-points glucose profiles|Change in lipid profile|Number of hypoglycaemic events|Number of adverse events
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
631
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2006-01
|
| Completion Date: |
2006-10
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-31
|
| Locations: |
Novo Nordisk Investigational Site, Bratislava, 811 05, Slovakia
|
| URL: |
https://clinicaltrials.gov/show/NCT01548248
|
